Evaluation of clostridium difficile-associated disease pressure as a risk factor for C difficile-associated disease

Archives of Internal Medicine

Volumn 167, Issue 10, 2007, Pages 1092-1097

  Dubberke, Erik R ^a,d   Reske, Kimberly A ^a   Olsen, Margaret A ^a   McMullen, Kathleen M ^b   Mayfield, Jennie L ^b   McDonald, L Clifford ^c   Fraser, Victoria J ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BARNES JEWISH HOSPITAL   (United States)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^d Box 8051 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMPICILLIN; ANTIBIOTIC AGENT; ANTIDIARRHEAL AGENT; ANTIINFECTIVE AGENT; CEPHALOSPORIN DERIVATIVE; CLINDAMYCIN; HISTAMINE H2 RECEPTOR ANTAGONIST; NARCOTIC AGENT; PROTON PUMP INHIBITOR; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ABDOMINAL SURGERY; ADULT; AGED; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL INFECTION; CASE CONTROL STUDY; CHEMOTHERAPY; CLOSTRIDIUM DIFFICILE; COHORT ANALYSIS; CONTROLLED STUDY; DEMOGRAPHY; DISEASE SEVERITY; FEMALE; HOSPITAL ADMISSION; HUMAN; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; UNIVARIATE ANALYSIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; DIARRHEA; ENTEROCOLITIS, PSEUDOMEMBRANOUS; FEMALE; HUMANS; MALE; MIDDLE AGED; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 34249712006     PISSN: 00039926     EISSN: 15383679     Source Type: Journal    
DOI: 10.1001/archinte.167.10.1092     Document Type: Article

References (33)

1. Johnson S, Gerding DN. Clostridium difficile-associated diarrhea. Clin Infect Dis. 1998;26:1027-1034.
2. Kyne L, Sougioultzis S, McFarland LV, Kelly CP. Underlying disease severity as a major risk factor for nosocomial Clostridium difficile diarrhea. Infect Control Hosp Epidemiol. 2002;23:653-659.
3. Kyne L, Farrell RJ, Kelly CP. Clostridium difficile. Gastroenterol Clin North Am. 2001;30:753-777.
4. Bignardi GE. Risk factors for Clostridium difficile infection. J Hosp Infect. 1998;40:1-15.
5. Macgowan AP, Brown I, Feeney R, et al. Clostridium difficile-associated diarrhoea and length of hospital stay. J Hosp Infect. 1995;31:241-244.
6. Borriello SP, Wilcox MH. Clostridium difficile infections of the gut: the unanswered questions. J Antimicrob Chemother. 1998;41(suppl C):67-69.
7. Gaynes R, Rimland D, Killum E, et al. Outbreak of Clostridium difficile infection in a long-term care facility. Clin Infect Dis. 2004;38:640-645.
8. Climo MW, Israel DS, Wong ES, et al. Hospital-wide restriction of clindamycin. Ann Intern Med. 1998;128:989-995.
9. Pépin J, Saheb N, Coulombe MA, et al. Emergence of fluoroquinolones as the predominant risk factor for Clostridium difficile-associated diarrhea: a cohort study during an epidemic in Quebec. Clin Infect Dis. 2005;41:1254-1260.
10. Eveillard M, Lancien E, Hidri N, et al. Estimation of methicillin-resistant Staphylococcus aureus transmission by considering colonization pressure at the time of hospital admission. J Hosp Infect. 2005;60:27-31.
11. Eveillard M, Lancien E, Barnaud G, et al. Impact of screening for MRSA carriers at hospital admission on risk-adjusted indicators according to the imported MRSA colonization pressure. J Hosp Infect. 2005;59:254-258.
12. Merrer J, Santoli F, Appere de Vecchi C, et al. "Colonization pressure" and risk of acquisition of methicillin-resistant Staphylococcus aureus in a medical intensive care unit. Infect Control Hosp Epidemiol. 2000;21:718-723.
13. Talon D, Vichard P, Muller A, et al. Modelling the usefulness of a dedicated cohort facility to prevent the dissemination of MRSA. J Hosp Infect. 2003;54:57-62.
14. Lucet JC, Paoletti X, Lolom I, et al. Successful long-term program for controlling methicillin-resistant Staphylococcus aureus in intensive care units. Intensive Care Med. 2005;31:1051-1057.
15. Muller AA, Mauny F, Bertin M, et al. Relationship between spread of methicillin-resistant Staphylococcus aureus and antimicrobial use in a French university hospital. Clin Infect Dis. 2003;36:971-978.
16. Puzniak LA, Leet T, Mayfield J, Kollef M, Mundy LM. To gown or not to gown: the effect on acquisition of vancomycin-resistant enterococci. Clin Infect Dis. 2002;35:18-25.
17. Bonten MJ, Slaughter S, Ambergen AW, et al. The role of "colonization pressure" in the spread of vancomycin-resistant enterococci: an important infection control variable. Arch Intern Med. 1998;158:1127-1132.
18. Puzniak LA, Mayfield J, Leet T, Kollef M, Mundy LM. Acquisition of vancomycin-resistant enterococci during scheduled antimicrobial rotation in an intensive care unit. Clin Infect Dis. 2001;33:151-157.
19. International Classification of Diseases, Ninth Revision, Clinical Modification. Washington, DC: Public Health Service, US Dept of Health and Human Services; 1988.
20. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med. 1985;13:818-829.
21. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373-383.
22. Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 1992;45:613-619.
23. McFarland LV, Surawicz CM, Stamm WE. Risk factors for Clostridium difficile carriage and C. difficile-associated diarrhea in a cohort of hospitalized patients. J Infect Dis. 1990;162:678-684.
24. Mylonakis E, Ryan ET, Calderwood SB. Clostridium difficile- associated diarrhea: a review. Arch Intern Med. 2001;161:525-533.
25. Rubin MS, Bodenstein LE, Kent KC. Severe Clostridium difficile colitis. Dis Colon Rectum. 1995;38:350-354.
26. Lawrence SJ, Puzniak LA, Shadel BN, et al. Clostridium difficile in the intensive care unit. Infect Control Hosp Epidemiol. 2007;28:123-130.
27. Barbut F, Petit JC. Epidemiology of Clostridium difficile- associated infections. Clin Microbiol Infect. 2001;7:405-410.
28. Modena S, Bearelly D, Swartz K, Friedenberg FK. Clostridium difficile among hospitalized patients receiving antibiotics: a case-control study. Infect Control Hosp Epidemiol. 2005;26:685-690.
29. Clabots CR, Johnson S, Olson MM, Peterson LR, Gerding DN. Acquisition of Clostridium difficile by hospitalized patients. J Infect Dis. 1992;166:561-567.
30. Johnson S, Gerding DN, Olson MM, et al. Prospective, controlled study of vinyl glove use to interrupt Clostridium difficile nosocomial transmission. Am J Med. 1990;88:137-140.
31. Kaatz GW, Gitlin SD, Schaberg DR, et al. Acquisition of Clostridium difficile from the hospital environment. Am J Epidemiol. 1988;127:1289-1294.
32. Mayfield JL, Leet T, Miller J, Mundy LM. Environmental control to reduce transmission of Clostridium difficile. Clin Infect Dis. 2000;31:995-1000.
33. McFarland LV, Mulligan ME, Kwok RY, Stamm WE. Nosocomial acquisition of Clostridium difficile infection. N Engl J Med. 1989;320:204-210.